Annual report of the Australian National Poliovirus Reference Laboratory, 2007
DOI:
https://doi.org/10.33321/cdi.2008.32.31Keywords:
poliovirus, acute flaccid paralysis, surveillance, enterovirus, importation, poliomyelitis, eradication, vaccinationAbstract
In July 2007, wild poliovirus type 1 was isolated from a patient suffering poliomyelitis in Melbourne, Australia with onset in Pakistan. The imported case of polio demonstrates the ongoing risk faced by polio-free countries until the global certification of polio eradication. The poliovirus was detected by the National Poliovirus Reference Laboratory (NPRL) for Australia; accredited by the World Health Organization (WHO). The NPRL acts as the national laboratory for the Pacific Islands, Brunei Darussalam and Papua New Guinea. Additionally, the NPRL functions as a regional reference laboratory for the WHO Western Pacific Region. The NPRL, in collaboration with the Australian Paediatric Surveillance Unit, co-ordinates surveillance for acute flaccid paralysis (AFP), a major clinical presentation of poliovirus infection. After classification of AFP cases by the Polio Expert Committee, the non-polio AFP rate for Australia in 2007 was 0.66 per 100,000 children aged less than 15 years, below the performance indicator of 1.0 per 100,000 set by the WHO. Adequate faecal sample collection totalled 48% (13/27) of eligible AFP notifications, below the 80% performance indicator recommended by the WHO. During 2007, 119 specimens were referred to the NPRL, 70 from AFP cases and 49 from other sources, including contacts of the wild poliovirus importation, all negative for poliovirus infection. Coxsackievirus A4 was isolated from 1 case and adenovirus from 2 cases. During 2007, 1,313 cases of poliomyelitis due to wild poliovirus infection were reported world-wide: 1,207 occurring in the 4 remaining polio endemic countries and 106 cases reported in 5 non-endemic countries. Commun Dis Intell 2008;32:308–315.
Downloads
References
World Heath Organisation. Global eradication of poliomyelitis by the year 2000 Resolution WHA41.28. Available from www.who.int/csr/ihr/polioresolution4128en.pdf
The global eradication of polio. Wild poliovirus. Case count by country. Available from: http://www.polioeradication.org/casecount.asp Accessed 18 June 2008.
Australian Government Department of Health and Ageing, National Health and Medical Research Council. The Australian Immunisation Handbook, 9th Edn. 2008:251–256.
Australian Government Department of Health and Ageing. Replacement of oral polio vaccine (OPV) with inactivated polio vaccine (IPV). Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/opvrep-qapub Accessed 2 August 2007.
Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L, et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 1998;36:2893–2899.
Wood DJ, Hull B. L20B cells simplify culture of polioviruses from clinical samples. J Med Virol 1999;58:188–182.
Thorley B, Kelly H, Roberts J. Importation of wild poliovirus into Australia, July 2007. Commun Dis Intell 2007;31:299
Kennett ML, Brussen KA, Wood DJ, van der Avoort HG, Ras A, et al. Australia’s last case of wild poliovirus infection. Commun Dis Intell 1999;23:76.
Thorley BR, Brussen KA, Elliott EJ, Kelly HA. Vigilance is required for Australia to remain polio free. Med J Aust 2006;184:474–475.
Durrheim DN, Massey IP, Kelly H. Re-emerging poliomyelitis – is Australia’s surveillance adequate? Commun Dis Intell 2006;30:275–277.
Downloads
Published
How to Cite
License
Copyright (c) 2008 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
